QR-333

· Quigley Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QR-333, covering 2009-01-08 to 2009-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy [Phase 2]